The MYH6 Gene Sick Sinus Syndrome Type 3 Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the MYH6 gene that are associated with Sick Sinus Syndrome Type 3 (SSS3). Sick Sinus Syndrome is a group of heart rhythm disorders that cause the heart's natural pacemaker, the sinus node, to function improperly, leading to irregular heartbeats (arrhythmias). The MYH6 gene encodes for the alpha-heavy chain subunit of cardiac myosin, a crucial protein for heart muscle contraction. Mutations in this gene can disrupt normal heart rhythm and lead to the development of SSS3.
This genetic test is crucial for individuals with a family history of Sick Sinus Syndrome or related cardiac arrhythmias, as it can provide definitive diagnosis of SSS3, enabling targeted management and treatment strategies. The test involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in the laboratory to detect any genetic abnormalities in the MYH6 gene.
At DNA Labs UAE, the cost of the MYH6 Gene Sick Sinus Syndrome Type 3 Genetic Test is 4400 AED. The test is conducted by a team of experienced geneticists and laboratory technicians using state-of-the-art genetic sequencing technologies, ensuring high accuracy and reliability of results. Upon completion, a detailed report is provided to the patient, which can be used as a basis for consultation with healthcare professionals to discuss potential treatment options and management strategies.
The CACNA1D gene plays a crucial role in the proper functioning of the sinoatrial node, which is responsible for initiating the heart's rhythm, as well as in hearing processes. Mutations in the CACNA1D gene can lead to sinoatrial node dysfunction and deafness, a rare genetic disorder characterized by an irregular heart rhythm and hearing loss. To diagnose this condition, a specific genetic test is available at DNA Labs UAE, designed to identify mutations in the CACNA1D gene. This test is essential for individuals experiencing symptoms related to heart rhythm irregularities and hearing impairment, or for those with a family history of the condition, as it can provide a definitive diagnosis. The test is priced at 4400 AED and offers a crucial step towards personalized treatment and management plans for affected individuals.
The SCN5A gene plays a critical role in the proper functioning of heart cells, particularly in the regulation of sodium channels essential for electrical signaling. Mutations in this gene have been associated with various cardiac conditions, including Sudden Infant Death Syndrome (SIDS), a tragic condition where seemingly healthy infants die unexpectedly during sleep. Understanding the genetic underpinnings of SIDS can help identify infants at increased risk and potentially guide preventive measures.
DNA Labs UAE offers a specialized genetic test targeting the SCN5A gene to assess the susceptibility to Sudden Infant Death Syndrome. This test is designed to detect mutations in the SCN5A gene that may predispose infants to heart rhythm abnormalities linked to SIDS. By identifying these genetic markers, parents and healthcare providers can be better informed about potential risks and consider appropriate monitoring or interventions.
The cost of the SCN5A gene test at DNA Labs UAE is 4400 AED. This investment in early detection and risk assessment can be invaluable for families with a history of SIDS or related cardiac conditions, providing them with crucial information for the care and safety of their infants.
The TSPYL1 Gene Sudden Infant Death with Dysgenesis of the Testes Syndrome (SIDDT) genetic test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the TSPYL1 gene that are associated with SIDDT. This rare genetic disorder is characterized by sudden infant death, typically within the first year of life, along with abnormalities in the development of the testes. The test plays a crucial role in diagnosing affected individuals, providing essential information for family planning, and guiding clinical management.
Priced at 4400 AED, the test involves analyzing the individual's DNA to detect specific mutations in the TSPYL1 gene that have been linked to the syndrome. The process requires a sample of the individual's blood or saliva, which is then subjected to advanced genetic sequencing techniques to scrutinize the gene of interest.
By identifying the presence of mutations in the TSPYL1 gene, the test can confirm a diagnosis of SIDDT, enabling healthcare providers to offer appropriate counseling and support to affected families. It is a vital tool for understanding the genetic basis of the syndrome and can help in the development of targeted therapies in the future.
DNA Labs UAE is equipped with state-of-the-art facilities and employs highly skilled professionals to conduct this complex genetic testing, ensuring accurate and reliable results for those undergoing testing for SIDDT.
The "GATA4 Gene Testicular Anomalies with or without Congenital Heart Disease Genetic Test" is a specialized diagnostic procedure available at DNA Labs UAE, designed to identify mutations in the GATA4 gene, which are associated with testicular anomalies and may also be linked to congenital heart disease. The GATA4 gene plays a crucial role in the development of the heart and gonads; mutations in this gene can lead to various developmental issues, including heart defects and abnormalities in the testes. This test is particularly valuable for individuals presenting symptoms of these conditions or those with a family history, providing essential information for diagnosis, management, and genetic counseling. The test is priced at 4400 AED and is conducted in the state-of-the-art facilities of DNA Labs UAE, ensuring high accuracy and reliability of the results.
The MKKS gene, also known as the McKusick-Kaufman syndrome genetic test, is a specific diagnostic tool used to identify mutations in the MKKS gene, which is linked to McKusick-Kaufman syndrome. This syndrome is a rare genetic disorder characterized by a combination of congenital anomalies including hydrometrocolpos, postaxial polydactyly, and congenital heart defects. The test is crucial for accurate diagnosis, allowing for appropriate management and genetic counseling for affected families.
Performed at DNA Labs UAE, a leading facility in genetic diagnostics, the test involves collecting a DNA sample, usually through a blood draw or cheek swab, and analyzing it for mutations in the MKKS gene. The cost of the test is 4400 AED, reflecting the sophisticated technology and expertise required to accurately identify mutations associated with the syndrome. This test is an invaluable resource for families with a history of McKusick-Kaufman syndrome, providing them with essential information for making informed health and reproductive decisions.
The MT-TC Gene MELAS Syndrome Genetic Test is a specialized diagnostic assessment available at DNA Labs UAE, designed to detect mutations in the mitochondrial gene MT-TC, which are associated with Mitochondrial Encephalopathy, Lactic Acidosis, and Stroke-like episodes (MELAS) syndrome. MELAS is a rare genetic disorder that affects various systems of the body, particularly the nervous system and muscles, leading to a wide range of symptoms including muscle weakness, headaches, loss of appetite, and more.
This test is crucial for individuals who exhibit symptoms of MELAS syndrome or have a family history of mitochondrial disorders, as it helps in confirming the diagnosis, thereby facilitating appropriate treatment and management strategies. Conducted in a state-of-the-art facility, the test requires a sample of the patient's blood or other tissues, which is then analyzed for specific genetic mutations.
The cost of the MT-TC Gene MELAS Syndrome Genetic Test at DNA Labs UAE is 4400 AED. This investment is vital for those at risk, as early detection and understanding of the specific genetic mutation present can significantly impact the management approach, potentially improving quality of life and outcomes for affected individuals.
The MT-TF Gene MELAS Syndrome Genetic Test is a specialized diagnostic examination designed to identify mutations in the mitochondrial transfer RNA phenylalanine gene (MT-TF), which are linked to Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like episodes (MELAS) syndrome. MELAS is a rare genetic disorder that affects multiple systems in the body, particularly the brain and the muscles. Symptoms can include muscle weakness and pain, recurrent headaches, loss of appetite, vomiting, and seizures, among others.
This genetic test is crucial for confirming a diagnosis of MELAS syndrome, enabling healthcare providers to tailor treatment plans to the specific needs of the patient. Early detection through this test can significantly improve the management of the condition, potentially slowing its progression and enhancing the quality of life for those affected.
Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, the test offers a comprehensive analysis of the MT-TF gene. The cost of the test is 4400 AED, reflecting the intricate technology and expertise required to accurately identify the genetic mutations associated with MELAS syndrome. This investment can be invaluable for affected individuals and their families, providing essential information for managing the condition effectively.
The MT-TL1 gene is associated with a condition known as MELAS syndrome, which stands for Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like episodes. This genetic disorder is characterized by a wide range of symptoms including muscle weakness, headaches, loss of appetite, seizures, and more. It is caused by mutations in the mitochondrial DNA, specifically in the MT-TL1 gene, which plays a crucial role in the production of transfer RNA (tRNA) for leucine, an essential component in the synthesis of proteins necessary for mitochondrial function.
To diagnose and assess the risk of MELAS syndrome, a genetic test targeting the MT-TL1 gene can be conducted. This test is crucial for individuals who exhibit symptoms of the syndrome or have a family history of mitochondrial disorders. It involves analyzing the DNA to identify mutations in the MT-TL1 gene that are known to cause the condition.
In the United Arab Emirates, DNA Labs UAE offers this specialized genetic test. The cost of the MT-TL1 gene test for MELAS syndrome at DNA Labs UAE is 4400 AED. This comprehensive test is performed in a state-of-the-art laboratory by experienced geneticists and clinicians who ensure accurate and reliable results. The test not only aids in the diagnosis of MELAS syndrome but also helps in the management and treatment planning for affected individuals, offering them and their families essential information about the condition.
The MT-TS1 gene, associated with MERRF/MELAS overlap syndrome, is crucial for understanding the genetic basis of these complex mitochondrial disorders. MERRF (Myoclonic Epilepsy with Ragged Red Fibers) and MELAS (Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like episodes) are part of a group of mitochondrial diseases that affect the nervous system and muscles, often leading to severe physical and cognitive impairments. The overlap syndrome signifies patients presenting symptoms of both conditions, making diagnosis and treatment more challenging.
The MT-TS1 gene encodes for a mitochondrial tRNA specific for serine, playing a vital role in protein synthesis within the mitochondria. Mutations in this gene disrupt mitochondrial function, leading to the systemic symptoms observed in MERRF/MELAS overlap syndrome. Given the genetic underpinnings of these conditions, genetic testing becomes a pivotal tool in the diagnostic process.
At DNA Labs UAE, a specialized genetic test targeting the MT-TS1 gene related to MERRF/MELAS overlap syndrome is available. This test is essential for confirming the diagnosis, understanding the disease's progression, and making informed decisions about management and treatment options. The test involves analyzing the patient's DNA to identify mutations in the MT-TS1 gene that are indicative of the syndrome.
The cost of the MT-TS1 related genetic test at DNA Labs UAE is 4400 AED. This investment in genetic testing can provide crucial information for affected individuals and their families, allowing for a better understanding of the condition and facilitating personalized treatment plans. It's important for patients and healthcare providers to consider this testing as part of a comprehensive approach to managing and treating mitochondrial diseases like the MERRF/MELAS overlap syndrome.
